淋巴瘤患者骨髓受累情况的评估：韩国血液学会淋巴瘤工作组共识会议报告
Assessment of bone marrow involvement in patients with lymphoma: report on a consensus meeting of the Korean Society of Hematology Lymphoma Working Party.
作者信息
Park Yong, Park Byung Bae, Jeong Ji Yun, Kim Wook Youn, Jang Seongsoo, Shin Bong Kyung, Lee Dong Soon, Han Jae Ho, Park Chan-Jeoung, Suh Cheolwon, Kim Insun, Chi Hyun-Sook
机构信息
Department of Internal Medicine, Korea University School of Medicine, Seoul, Korea.
Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.
出版信息
Korean J Intern Med. 2016 Nov;31(6):1030-1041. doi: 10.3904/kjim.2015.006. Epub 2016 Nov 1.
Abstract
In September 2011, the Korean Society of Hematology Lymphoma Working Party held a nationwide conference to establish a consensus for assessing bone marrow (BM) involvement in patients with lymphoma. At this conference, many clinicians, hematopathologists, and diagnostic hematologists discussed various topics for a uniform consensus in the evaluation process to determine whether the BM is involved. Now that the discussion has matured sufficiently to be published, we herein describe the consensus reached and limitations in current methods for assessing BM involvement in patients with lymphoma.
摘要
2011年9月，韩国血液学会淋巴瘤工作组召开了一次全国性会议，旨在就评估淋巴瘤患者骨髓（BM）受累情况达成共识。在此次会议上，众多临床医生、血液病理学家和诊断血液学家就评估过程中的各种议题展开讨论，以达成关于确定BM是否受累的统一共识。鉴于相关讨论已成熟到足以发表，我们在此描述所达成的共识以及当前评估淋巴瘤患者BM受累情况方法的局限性。
相似文献
1
Assessment of bone marrow involvement in patients with lymphoma: report on a consensus meeting of the Korean Society of Hematology Lymphoma Working Party.淋巴瘤患者骨髓受累情况的评估：韩国血液学会淋巴瘤工作组共识会议报告
Korean J Intern Med. 2016 Nov;31(6):1030-1041. doi: 10.3904/kjim.2015.006. Epub 2016 Nov 1.
2
Morphologic, flow cytometric and cytogenetic evaluation of bone marrow involvement in B-cell lymphoma.B细胞淋巴瘤骨髓受累的形态学、流式细胞术及细胞遗传学评估
Haematologica. 2003 Dec;88(12):1358-65.
3
Reproducibility of SOX-11 detection in decalcified bone marrow tissue in mantle cell lymphoma patients.套细胞淋巴瘤患者脱钙骨髓组织中SOX-11检测的可重复性。
Hum Pathol. 2017 Jan;59:94-101. doi: 10.1016/j.humpath.2016.09.018. Epub 2016 Oct 5.
4
Bone marrow trephine biopsy involvement by lymphoma: review of histopathological features in 511 specimens and correlation with diagnostic biopsy, aspirate and peripheral blood findings.骨髓活检中淋巴瘤累及的回顾性研究：511 例标本的组织病理学特征与诊断性活检、抽吸物和外周血检查的相关性研究。
J Clin Pathol. 2014 May;67(5):389-95. doi: 10.1136/jclinpath-2013-201520. Epub 2013 Dec 10.
5
Detection of lymphoid neoplasms in bone marrow by flow cytometric analysis and comparison to bone marrow aspiration and biopsy.通过流式细胞术分析检测骨髓中的淋巴样肿瘤，并与骨髓穿刺和活检结果进行比较。
J Med Assoc Thai. 2013 Feb;96 Suppl 2:S210-5.
6
Characteristics and clinical implications of reactive germinal centers in the bone marrow.骨髓中反应性生发中心的特征及临床意义
Hum Pathol. 2017 Oct;68:7-21. doi: 10.1016/j.humpath.2017.03.024. Epub 2017 Apr 17.
7
ICSH guidelines for the standardization of bone marrow immunohistochemistry.国际血液学标准化委员会（ICSH）骨髓免疫组织化学标准化指南
Int J Lab Hematol. 2015 Aug;37(4):431-49. doi: 10.1111/ijlh.12365. Epub 2015 May 15.
8
Bone marrow involvement in lymphoma: the importance of marrow magnetic resonance imaging.淋巴瘤的骨髓受累：骨髓磁共振成像的重要性
Leuk Lymphoma. 1998 May;29(5-6):515-22. doi: 10.3109/10428199809050911.
9
Diagnosis and classification of malignant lymphoma and related entities in the bone marrow trephine biopsy.骨髓活检中恶性淋巴瘤及相关病变的诊断与分类
Pathobiology. 2007;74(2):133-43. doi: 10.1159/000101712.
10
Can flow cytometry of bone marrow aspirate predict outcome of patients with diffuse large B cell lymphoma? A retrospective single centre study.骨髓穿刺液的流式细胞术能否预测弥漫性大B细胞淋巴瘤患者的预后？一项回顾性单中心研究。
Hematol Oncol. 2015 Mar;33(1):42-7. doi: 10.1002/hon.2127. Epub 2014 Jan 27.
引用本文的文献
1
Assessment of Bone Marrow Involvement in B-Cell non-Hodgkin Lymphoma Using Immunoglobulin Gene Rearrangement Analysis with Next-Generation Sequencing.采用下一代测序的免疫球蛋白基因重排分析评估 B 细胞非霍奇金淋巴瘤骨髓累及情况。
J Clin Lab Anal. 2024 Mar;38(6):e25027. doi: 10.1002/jcla.25027. Epub 2024 Mar 20.
2
Challenges Encountered and Pattern-Based Analysis of Bone Marrow Biopsy in Lymphomas: An Institutional Experience.淋巴瘤骨髓活检中遇到的挑战及基于模式的分析：一项机构经验
J Lab Physicians. 2022 Aug 17;15(1):69-77. doi: 10.1055/s-0042-1751318. eCollection 2023 Mar.
3
The Profile of MicroRNA Expression in Bone Marrow in Non-Hodgkin's Lymphomas.非霍奇金淋巴瘤患者骨髓中微小RNA表达谱
Diagnostics (Basel). 2022 Mar 3;12(3):629. doi: 10.3390/diagnostics12030629.
4
Diagnostic Accuracy and Prognostic Relevance of Immunoglobulin Heavy Chain Rearrangement and 18F-FDG-PET/CT Compared With Unilateral Bone Marrow Trephination for Detecting Bone Marrow Involvement in Patients With Diffuse Large B-Cell Lymphoma.免疫球蛋白重链重排与 18F-FDG-PET/CT 检测弥漫性大 B 细胞淋巴瘤患者骨髓侵犯的诊断准确性和预后相关性与单侧骨髓活检比较。
J Korean Med Sci. 2022 Jan 3;37(1):e2. doi: 10.3346/jkms.2022.37.e2.
5
Bone Marrow Lymphoid Niche Adaptation to Mature B Cell Neoplasms.骨髓淋巴样龛适应成熟 B 细胞肿瘤。
Front Immunol. 2021 Dec 8;12:784691. doi: 10.3389/fimmu.2021.784691. eCollection 2021.
6
Indications and diagnostic value of bone marrow examination in HIV-positive individuals: A 3-year review at Tygerberg Hospital.HIV阳性个体骨髓检查的适应症及诊断价值：泰格堡医院三年回顾
S Afr J Infect Dis. 2021 Aug 23;36(1):273. doi: 10.4102/sajid.v36i1.273. eCollection 2021.
7
First report of the unique expression of RECAF (receptor for alfa feto-protein) in adult B-NHL/CLL patients.成人B细胞非霍奇金淋巴瘤/慢性淋巴细胞白血病患者中甲胎蛋白受体（RECAF）独特表达的首次报道。
Blood Res. 2020 Dec 31;55(4):253-261. doi: 10.5045/br.2020.2020070.
8
Impact and Intricacies of Bone Marrow Microenvironment in B-cell Lymphomas: From Biology to Therapy.骨髓微环境对 B 细胞淋巴瘤的影响及其复杂性：从生物学到治疗。
Int J Mol Sci. 2020 Jan 30;21(3):904. doi: 10.3390/ijms21030904.
本文引用的文献
1
Chronic lymphocytic leukemia: a clinical review including Korean cohorts.慢性淋巴细胞白血病：一项包括韩国队列的临床综述
Korean J Intern Med. 2016 May;31(3):433-43. doi: 10.3904/kjim.2015.074. Epub 2016 Apr 5.
2
Role of frontline autologous stem cell transplantation in young, high-risk diffuse large B-cell lymphoma patients.一线自体干细胞移植在年轻高危弥漫性大B细胞淋巴瘤患者中的作用。
Korean J Intern Med. 2015 May;30(3):362-71. doi: 10.3904/kjim.2015.30.3.362. Epub 2015 Apr 29.
3
Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma.自体移植作为侵袭性非霍奇金淋巴瘤的巩固治疗。
N Engl J Med. 2013 Oct 31;369(18):1681-90. doi: 10.1056/NEJMoa1301077.
4
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.EuroFlow 抗体试剂盒，用于标准化 n 维流式细胞术免疫表型分析正常、反应性和恶性白细胞。
Leukemia. 2012 Sep;26(9):1908-75. doi: 10.1038/leu.2012.120. Epub 2012 May 3.
5
Hodgkin lymphoma.霍奇金淋巴瘤
J Natl Compr Canc Netw. 2011 Sep 1;9(9):1020-58. doi: 10.6004/jnccn.2011.0086.
6
Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP.R-CHOP 治疗弥漫性大 B 细胞淋巴瘤中骨髓累及一致与不一致对预后的影响。
J Clin Oncol. 2011 Apr 10;29(11):1452-7. doi: 10.1200/JCO.2010.33.3419. Epub 2011 Mar 7.
7
Imaging of bone marrow involvement in lymphoma: state of the art and future directions.淋巴瘤骨髓受累的影像学检查：现状与未来方向
ScientificWorldJournal. 2011 Feb 14;11:391-402. doi: 10.1100/tsw.2011.40.
8
Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10.急性白血病和淋巴增殖性疾病的免疫表型分析：欧洲白血病网工作组 10 的共识建议。
Leukemia. 2011 Apr;25(4):567-74. doi: 10.1038/leu.2010.312. Epub 2011 Jan 21.
9
Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): single institution experience in a large cohort of patients.原发性眼附属器黏膜相关淋巴组织淋巴瘤（MALT）：在一大群患者中单中心的经验。
Br J Haematol. 2011 Jan;152(1):72-80. doi: 10.1111/j.1365-2141.2010.08429.x. Epub 2010 Nov 18.
10
Stage IV marginal zone B-cell lymphoma--prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study.IV 期边缘区 B 细胞淋巴瘤——预后因素和利妥昔单抗的作用：改善淋巴瘤生存研究联盟（CISL）研究。
Cancer Sci. 2010 Nov;101(11):2443-7. doi: 10.1111/j.1349-7006.2010.01698.x.
Zotero 插件